EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Incidence of Multiple Fusions in a Series of Pediatric Soft Tissue and Bone Tumors

Anastasia MacKeracher, Anthony Arnoldo iD, Robert Siddaway iD, Lea F Surrey, Gino R Somers iD

Pediatric and Developmental Pathology · 2024

DOI: 10.1177/10935266231199928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric and Developmental Pathology, 2024. Verfasst von Anastasia MacKeracher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Bone Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dr. Daria Haust Studentship at the Hospital for Sick Children.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Next generation sequencing (NGS) has increased the detection of fusion genes in cancer. NGS has found multiple fusions in single tumor samples; however, the incidence of this in pediatric soft tissue and bone tumors (PSTBTs) is not well documented. The aim of this study is to catalogue the incidence of multiple fusions in a series of PSTBTs, and apply a modified gene fusion classification system to determine clinical relevance. Methodology: RNA from 78 bone and soft tissue tumors and 7 external quality assessment samples were sequenced and analyzed using recently-described Metafusion (MF) software and classified using a modification of previously-published schema for fusion classification into 3 tiers: 1, strong clinical significance; 2, potential clinical significance; and 3, unknown clinical significance.

Results

One-hundred forty-five fusions were detected in 85 samples. Fifty-five samples (65%) had a single fusion and 30 (35%) had more than 1 fusion. No samples contained more than 1 tier 1 fusion. There were 40 tier 1 (28%), 36 tier 2 (24%), and 69 (48%) tier 3 fusions.

Conclusions

A significant percentage of PSTBTs harbor more than 1 fusion, and by applying a modified fusion classification scheme, the potential clinical relevance of such fusions can be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsSoft Tissue NeoplasmsHumansChildIncidenceGene FusionBase SequenceHigh-Throughput Nucleotide SequencingOncogene Proteins, Fusion

Stichwörter der Autor:innen

bone tumorsfusion classificationfusion genesfusion pathogenicitymolecular oncologysoft tissue tumors

Substanzen

Oncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Anthony Arnoldo, Robert Siddaway, Gino R Somers

Förderung

  • Dr. Daria Haust Studentship at the Hospital for Sick Children

Zitieren

APA

MacKeracher, A., Arnoldo, A., Siddaway, R., Surrey, L. F., & Somers, G. R. (2024). The Incidence of Multiple Fusions in a Series of Pediatric Soft Tissue and Bone Tumors. Pediatric and Developmental Pathology. https://doi.org/10.1177/10935266231199928

Vancouver

MacKeracher A, Arnoldo A, Siddaway R, Surrey LF, Somers GR. The Incidence of Multiple Fusions in a Series of Pediatric Soft Tissue and Bone Tumors. Pediatric and Developmental Pathology. 2024. doi:10.1177/10935266231199928

BibTeX
@article{MacKeracher2024,
  author = {MacKeracher, Anastasia and Arnoldo, Anthony and Siddaway, Robert and Surrey, Lea F and Somers, Gino R},
  title = {The Incidence of Multiple Fusions in a Series of Pediatric Soft Tissue and Bone Tumors},
  journal = {Pediatric and Developmental Pathology},
  year = {2024},
  doi = {10.1177/10935266231199928}
}
Kostenlos starten →